ARTA
RARE icon

A.R.T. Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

A.R.T. Advisors’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,566
Closed -$409K – 771
2019
Q4 		$409K Sell
9,566
-17,800
-65% -$734K 0.02% 920
2019
Q3 		$1.17M Buy
+27,366
New +$1.49M 0.06% 483
2017
Q4 		– Sell
-47,245
Closed -$2.52M – 1613
2017
Q3 		$2.52M Buy
+47,245
New +$2.8M 0.13% 211
2017
Q1 		– Sell
-3,400
Closed -$239K – 1660
2016
Q4 		$239K Buy
+3,400
New +$241K 0.01% 1009
2016
Q2 		– Sell
-6,153
Closed -$389K – 1582
2016
Q1 		$389K Buy
6,153
+3,100
+102% +$203K 0.02% 953
2015
Q4 		$342K Buy
+3,053
New +$305K 0.02% 1004
2015
Q3 		– Sell
-18,493
Closed -$1.89M – 1544
2015
Q2 		$1.89M Buy
+18,493
New +$1.44M 0.06% 470

Other funds holding RARE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return